In addition, an Egyptian study found that the rates of CYP2D6 IM and PM variants were higher in CML than in controls (28% vs. 5% and 8% vs. 0%, respectively p = 0.004) [45]. Here, CYP2D6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.